Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04138381 |
|---|---|
| Brief Title: | Selinexor as a Single Agent and in Combination With Imatinib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors. (SeliGIST) |
| First Submitted : | September 16, 2019 |
| First Submitted that Met QC Criteria : | October 22, 2019 |
| First Posted : | October 24, 2019 |
| Last Update Submitted that Met QC Criteria : | October 21, 2020 |
| Last Update Posted : | October 23, 2020 |